CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 21 enrolled
Drug / intervention
1.5 microns at 50mg +3 moredrug
Likely dose
1.5 microns at 50mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01662778
NCT01662778Phase 4Completed
CompareCT.gov

The Clinical Effect in Asthma of Inhaled Fluticasone Propionate Delivered as Monodisperse Aerosols

Imperial College London·interventional·Posted Aug 10, 2012·Updated Nov 18, 2019

In Brief

A Phase 4 clinical trial evaluating 1.5 microns at 50mg, 6 microns at 50mg, and 2 other interventions for Asthma. Completed, enrolled 21 participants across 2 sites.

Detailed Summary

The objective here is to determine that the efficiency of inhaled drug delivery can be improved by using a fine mist cloud of drug particles (as opposed to a coarse mist cloud of drug particles). This information will be valuable in designing new inhalers in order to improve their beneficial effects and reduce their side effects, by using the least possible drug dose to achieve a good patient response. .

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited Kingdom
CollaboratorsGlaxoSmithKline

Timeline

Phase 4CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 10, 2012
Enrollment StartDec 1, 2011
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 13.9 years ago

Interventions

1.5 microns at 50mgdrug

STAG generated monodisperse 1.5micron particles

6 microns at 50mgdrug

STAG generated monodisperse 6 micron particles

Placebo Comparatordrug

No drug just solvent

MDI FPdrug